CEC Capital
Finance · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
1333 2nd St Ste 600, Santa Monica, Calif...Phone Number
+86 1085192080Website
www.ceccapitalgroup.comRevenue
$17.2 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
2
1
2
1
About CEC Capital
易凯资本 is a financial services firm specializing in mergers and acquisitions, private equity financing, and asset management. The company aims to create value for clients and industries through innovative integration and connects global quality assets with premium capital. They provide in-depth industry research and insights, particularly focusing on the healthcare sector and the evolving Chinese market. Their intended clients include institutional investors and innovative entrepreneurs seeking to enhance their market presence.Explore more
CEC Capital Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is CEC Capital your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at CEC Capital
CEC Capital, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once CEC Capital has new funding data
Product Launch: Get notified when CEC Capital launches new products
Check out if CEC Capital is spiking on competitors!
Earning: See what the market has to say on CEC Capital recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if CEC Capital has recently received funding, and reach out quickly before it becomes old news!
Click to see if CEC Capital had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined CEC Capital as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
CEC Capital is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
CEC Capital is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about CEC Capital.
CEC Capital Tech Stack
A closer look at the technologies used by CEC Capital
See more technologies
CEC Capital News & Media
Therorna completes Series A financing to accelerate pipeline development and clinical transformation of circRNA-based platform
BEIJING, June 20, 2022 /PRNewswire/ -- Therorna Inc., a China-based biotech company specialized in the development of cutting-edge circular RNA (or circRNA) technology-based new vaccines and therapies, announced the completion of a US$42 million Series A financing round. The round was...SyMap Medical Ltd. Closes Largest Financing Round in Renal Denervation Field
SUZHOU, China, Dec. 7, 2021 /PRNewswire/ -- SyMap Medical (SyMap) announced its latest financing round of nearly $100 million led by Primavera Capital and VMS Group, with the participation of existing investors Simiao Equity Investment and Sequoia Capital China. CEC Capital served as the exclusive financial advisor for this transaction. As the world's largest financing round in the renal denervation (RDN) field to date, the funds will be used to accelerate global clinical trials forLynk Pharmaceuticals announced the completion of Series B financing of $50 million
HANGZHOU, China, Aug. 27, 2021 /PRNewswire/ -- Lynk Pharmaceuticals CO., LTD (hereinafter referred to as "Lynk Pharmaceuticals"), an innovative pharmaceutical R&D company, today announced that it has successfully completed Series B financing of $50 million, with Lilly Asia Ventures (LAV) as lead investor, New Alliance Capital and Hangzhou HEDA Biological Medicine Venture Capital Partnership (L.L.P.) as co-investors, and its original shareholders Legend Capital and Med-Fine Capital as participatiWuXi Diagnostics Secures US$150 Million Series B Financing to Accelerate Market Penetration in Global Diagnostics Sector
SHANGHAI, Feb. 23, 2021 /PRNewswire/ -- WuXi Diagnostic Investment (Cayman) Limited ("WuXi Diagnostics") announced that it has completed US$150 million in series B funding, joined by new investors including Thermo Fisher Scientific Inc. ("Thermo Fisher"), Shiyu Capital ("SHIYU"), ABC...
Read more news
Top Finance Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding CEC Capital
Sign Up For FreeTo access detailed company insights
易凯资本 is a financial services firm specializing in mergers and acquisitions, private equity financing, and asset management. The company aims to create value for clients and industries through innovative integration and connects global quality assets with premium capital. They provide in-depth industry research and insights, particularly focusing on... Read More
